accountApril 28 (Bloomberg) -- Johnson & Johnson���s newfound dominance of the orthopedic-device market, cemented by its...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
JOHNSON & JOHNSON
Johnson & Johnson is a global pharmaceutical, medical devices and consumer packaged goods manufacturer. Founded in 1886, J&J now includes about 250 subsidiaries in more than 57 countries. A household name in the U.S., the company’s products are sold in more than 175 countries. The topic covers Johnson & Johnson the company, its products and market updates.
Johnson & Johnson is part of Business Exchange, suggested by
Carlton St Bernard.
This topic contains
1,302 news
and
1,890 blog
items.
Read updated news, blogs, and resources about Johnson & Johnson. Find user-submitted articles and reactions on Johnson & Johnson from
like-minded professionals.
News
Please add new articles to this topic
Nations Face Quandary in Syria Karzai Told to Dump U.S. S&P���s Japan Outlook Goes Negative Corporate J&J to...
It?s Deal Time: Johnson & Johnson is buying Synthes, which makes surgical devices used for orthopedic and traumatic...
Reuters Johnson & Johnson���s plan to buy Swiss-listed medical device maker Synthes will probably succeed in the...
CompaniesEconomy International The Buzz Street Sweep Corrections Pre-market Trading After-hours Trading US Stocks Bonds...
US healthcare giant Johnson & Johnson (J&J) has agreed to buy Swiss medical devices company Synthes in a deal...
April 27 (Bloomberg) -- Johnson & Johnson agreed to buy Synthes Inc. for $21.3 billion, adding devices to treat...
also out on Wednesday. Economists surveyed by Briefing.com expect an increase of 1.8% in March.Companies: Johnson &...
Extract not available.
Extract not available.
test leadership already grappling with manufacturing problems and investor concerns about mismanagement.
April 27 (Bloomberg) -- Johnson & Johnson agreed to buy Synthes Inc. for $21.3 billion in the biggest purchase of...
Extract not available.
by the European Medicines Agency. Telaprevir would be marketed in Europe by Vertex and New Brunswick, New Jersey-based...
equipment improved and the company reduced spending. Synthes Inc. climbed 1.5 percent to 148.7 francs as Johnson &...
The email address you have entered is already in use. Please re-enter the email address.
well as its first ever press conference as well as the impact on the market. In deal news, Johnson & Johnson added...
Extract not available.
personal data and create visualizations, reports Nick Bilton on the Bits blog. Read more �� Previous Article Inside...
A general view shows Swiss medical devices maker Synthes' headquarters in Oberdorf, April 25, 2011. Johnson &...
CNBC talks with Johnson & Johnson chief executive, William C. Weldon, about the strategy behind the bid to buy...
Extract not available.
Extract not available.
well as its first ever press conference as well as the impact on the market. In deal news, Johnson & Johnson shed 0.
Top Sources: Johnson & Johnson
- Financial Times
- BusinessWeek
- Reuters
- Motley Fool
- TheStreet.com
- thedeal.com
- New York Times
- Wall Street Journal Online
- MarketWatch
- youtube.com
Post a Job
Jobs in this Topic
Rep, Phlebotomy Services (part-time) and in client office position located in Johnson Ferry are
Questdiagnostics
|
Atlanta, GA
Posted: Apr 3